跳至主要内容
临床试验/NCT02155439
NCT02155439已完成4 期

Treatment of Keloidscars With Intralesional Triamcinolone and 5-fluorouracil Injections-prospective, Randomized, Controlled Trial - Pilot Study

Tampere University Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2014年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
50
试验地点
1
主要终点
Symptoms (pain, itching) of keloids and appearance of keloid

研究概览

简要总结

The aim of study is examine the efficacy of intralesional 5-fluorouracil injections in keloid disease treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Person who has a keloidscar which could be treated with injection treatment

排除标准

  • Pregnancy, lactating, renal or liver failure

研究组 & 干预措施

Triamcinolone

Active Comparator

kortikosteroid

干预措施: 5-fluorouracil (Drug)

5-fluorouracil

Active Comparator

antimitotic drug

干预措施: Triamcinolone (Drug)

结局指标

主要结局

Symptoms (pain, itching) of keloids and appearance of keloid

时间窗: baseline and one year

Change from baseline symptoms of scars baseline at one year with POSAS score

次要结局

  • Concentration change of hemoglobin and melanin(0 week, 3 week, 6 week, 12 week, 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kristiina Hietanen

MD

Tampere University Hospital

研究点 (1)

Loading locations...

相似试验